Online inquiry

IVTScrip™ mRNA-Human ARHGEF18, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26811MR)

This product GTTS-WK26811MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGEF18 protein. This product can be used in Naive CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001130955.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23370
UniProt ID Q6ZSZ5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF18, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26811MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK20368MR IVTScrip™ mRNA-Human AOAH, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AOAH
GTTS-WK17921MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD36BP1
GTTS-WK28579MR IVTScrip™ mRNA-Human ARGLU1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARGLU1
GTTS-WK23895MR IVTScrip™ mRNA-Human ASB13, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASB13
GTTS-WK14740MR IVTScrip™ mRNA-Human AJUBA, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AJUBA
GTTS-WK22007MR IVTScrip™ mRNA-Human ARHGEF10, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF10
GTTS-WK15031MR IVTScrip™ mRNA-Human AIF1L, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AIF1L
GTTS-WK21390MR IVTScrip™ mRNA-Human Albumin, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Albumin
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW